Avidity Biosciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
/ 
Frequently asked questions
To buy Avidity Biosciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Avidity Biosciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Avidity Biosciences Inc. is RNA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Avidity Biosciences Inc. has its primary listing on NASDAQ. You can trade Avidity Biosciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Avidity Biosciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Avidity Biosciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Avidity Biosciences Inc..